SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-059264
Filing Date
2021-04-30
Accepted
2021-04-30 17:20:35
Documents
6
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm212677d2_def14a.htm DEF 14A 1201575
2 GRAPHIC tm212677d1_def14aimg001.jpg GRAPHIC 24254
3 GRAPHIC tm212677d1_def14aimg002.jpg GRAPHIC 10013
4 GRAPHIC tm212677d1_def14aimg003.jpg GRAPHIC 11968
5 GRAPHIC tm212677d1_def14aimg005.jpg GRAPHIC 444458
6 GRAPHIC tm212677d1_def14a-img02.jpg GRAPHIC 264620
  Complete submission text file 0001104659-21-059264.txt   2242333
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36294 | Film No.: 21879901
SIC: 2834 Pharmaceutical Preparations